Duligotuzumab
Duligotuzumab is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Merck KGaA and ImClone Systems.
Mechanism of Action[edit | edit source]
Duligotuzumab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2). By binding to these receptors, duligotuzumab inhibits the growth and proliferation of cancer cells that overexpress these receptors.
Clinical Trials[edit | edit source]
Duligotuzumab has been studied in clinical trials for the treatment of various types of cancer, including head and neck cancer, colorectal cancer, and non-small cell lung cancer. However, the results of these trials have been mixed, and the drug is not currently approved for use in any country.
Side Effects[edit | edit source]
Like all drugs, duligotuzumab can cause side effects. The most common side effects reported in clinical trials include fatigue, nausea, diarrhea, and skin rash. In some cases, these side effects can be severe and may require medical attention.
See Also[edit | edit source]
- Monoclonal antibodies
- Epidermal growth factor receptor
- Human epidermal growth factor receptor 2
- Cancer treatment
| Duligotuzumab Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
